By modulating the antioxidant systems, cellular metabolism, and the remodeling of extracellular matrix, TXNIP exerts tumor suppressive activities in various human cancers such as colorectal, liver, breast, and lung carcinomas and hematologic malignancies, including AML [33, 34, 35, 36]. Here, TXNIP is linked to acute myeloid leukemia.